-
May 9, 2019 Lupin and Aptissen announce exclusive distribution agreement of Synolis VA for Canada
-
May 7, 2019 Lupin receives tentative U.S. FDA approval for Fosaprepitant for Injection
-
April 30, 2019 Lupin in alliance with Natco receives FDA approval for Bosentan Tablets
-
April 16, 2019 Lupin receives FDA approval for Fluoxetine Tablets USP
-
April 12, 2019 Lupin launches Testosterone Gel
-
April 11, 2019 Lupin receives FDA approval for Testosterone Gel
-
April 10, 2019 Lupin launches Fluoxetine Tablets USP
-
April 3, 2019 Lupin Bioresearch Centre completes fifth successful U.S. FDA inspection
-
April 2, 2019 Lupin’s Pithampur Unit-3 (Indore) receives EIR from U.S. FDA
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications